Moolec Science (NASDAQ:MLEC) and CC Neuberger Principal Holdings II (NYSE:PRPB) Head-To-Head Survey

Moolec Science (NASDAQ:MLEC) and CC Neuberger Principal Holdings II (NYSE:PRPB) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Volatility & Risk

Moolec Science has a beta of -0.54, indicating that its stock price is 154% less volatile than the S&P 500. Comparatively, CC Neuberger Principal Holdings II has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500.

Profitability

This table compares Moolec Science and CC Neuberger Principal Holdings II’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-150.27%	-87.89%	-33.26%
CC Neuberger Principal Holdings II	N/A	N/A	-1.58%

Earnings & Valuation

This table compares Moolec Science and CC Neuberger Principal Holdings II’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$2.90 million	13.74	-$51.79 million	N/A	N/A
CC Neuberger Principal Holdings II	N/A	N/A	-$2.70 million	N/A	N/A

CC Neuberger Principal Holdings II has lower revenue, but higher earnings than Moolec Science.

Insider & Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 0.1% of CC Neuberger Principal Holdings II shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations and price targets for Moolec Science and CC Neuberger Principal Holdings II, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	3	0	3.00
CC Neuberger Principal Holdings II	0	0	0	0	N/A

Moolec Science currently has a consensus target price of $5.50, suggesting a potential upside of 418.87%. Given Moolec Science’s higher possible upside, research analysts plainly believe Moolec Science is more favorable than CC Neuberger Principal Holdings II.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About CC Neuberger Principal Holdings II

CC Neuberger Principal Holdings II does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. CC Neuberger Principal Holdings II was incorporated in 2020 and is based in New York, New York.